Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP1) has been known to have oncogenic properties during latent infection in nasopharyngeal carcinoma (NPC). This evidence concerns the gene PDLIM7 and disease arising from reactivation of latent virus.